Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS. AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS, CII Initial U.S. Approval: 1960
Medication labelWhy this: Advisory · dailymed-prescription
Amphetamine extended-release orally disintegrating tablets is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [see Clinical Studies ( 14 )].
- generic_name
- amphetamine extended-release
- product_names
- Amphetamine Extended-Release
- ndc
- 62542-005, 62542-005-30, 62542-010, 62542-010-30, 62542-015, 62542-015-30, 62542-020, 62542-020-30, 62542-025, 62542-025-30, 62542-030, 62542-030-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en